Merger Update: Pharm-a-Care/Haliborange

ANTICIPATED ACQUISITION BY PHARM-A-CARE LABORATORIES PTY LIMITED OF THE HALIBORANGE BUSINESS OF THE PROCTER & GAMBLE COMPANY

Invitation to comment: Closes on 19 May 2020

The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

To assist it with this assessment, the CMA invites comments on the transaction from any interested party.

These comments should be provided by the deadline set out above to:

Case officer name: Rafia Saif

Tel no: 020 3738 6932

E-mail: rafia.saif@cma.gov.uk 

Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.